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A  central event in the replication cycle of retroviruses is the encapsidation of two 
homologous strands of genomic RNA. A critical step in this process is the dimerization 
of the genomic RNA prior to or during encapsidation and budding. In human 
immunodeficiency virus type-1 (HlV-1) this process has been well documented. HTV-l 
initiates dimerization through a stem-loop (SLl) located in the 5’-untranslated region of 
the viral genome. SLl contains an autocomplementary hexonucleotide sequence that 
interacts with its homologous counterpart by a “kissing-loop” mechanism. Mutations or 
deletions in SLl have been shown to affect at least three steps of retroviral replication: 
dimerization, encapsidation, and reverse transcription. Additionally, mutations or 
deletions in SLl decreased viral mfectivitiy by one to three orders of magnitude. 
Although much is known regarding this process in HTV-l, the dimerization mechanism 
used by human immunodeficiency virus type-2 (HlV-2) has yet to be definitively 
demonstrated. The research presented for this thesis was designed to analyze the 
structure of conformational variants of HlV-2 leader region RNA. Using solution 
structure probing, various HTV-2 RNA constructs were structurally analyzed in order to 
elucidate conformational changes correlated with dimerization behavior.
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Introduction
Background
In 1892, the Russian Scientist Dimitrii Ivanowsky provided the first report of a 
pathogenic agent smaller than any known bacterium. He observed that upon filtration to 
remove bacteria fi*om extracts and culture media, the causative agent of the tobacco 
mosaic virus was not retained. Further work by Beijerinck, Loeffler, Frosch and others 
verified that not only did pathogens smaller than bacteria exist, they also seemed 
incapable of replicating outside of the host organism. These infectious agents were 
labeled ultrafilterable viruses and eventually were simply called viruses, fi-om the Latin 
term meaning “poison.”
In 1902, yellow fever became the first human virus to be identified. Yellow fever 
had been known to be widespread in tropical countries since the 15* century, resulting in 
devastating epidemics. However, the disease was not directly contagious and early 
searches for an infectious agent proved to be unsuccessful. In 1880, Carlos Juan Finlay, a 
Cuban physician, postulated that a blood-sucking insect played a role in the transmission 
of the disease. This paved the way for a study on the etiology of yellow fever 
commissioned by the U.S. Army in 1889, in part due to the high incidence of the disease 
among U.S. soldiers who were occupying Cuba at the time. Colonel Walter Reed along 
with Dr. Jesse Lazear headed the study. Dr. Lazear was the first person to be 
experimentally infected with blood fi’om a mosquito and his resultant death strongly
suggested that mosquitoes did indeed transmit yellow fever. Ultimately, Reed’s studies 
proved conclusively that mosquitoes are the disease vector for yellow fever.
Additionally, they demonstrated that human blood was the source of the infection. The 
introduction of mosquito control dramatically reduced the incidence of yellow fever by 
1902, and mosquito control remains an important method of control for the disease to this 
day.
During the early part of the 20* century the discovery of other viruses occurred at 
a slow pace, due in part to the dangers of working with viruses, as evidenced by yellow 
fever, and also to die lack of experimental techniques available. However, with the 
advent of the electron microscope and new molecular biological techniques the list of 
viruses rapidly expanded. A recent report from the International Committee on 
Taxonomy of Viruses (ICTY) states that there are approximately 4000 viruses that infect 
plants, animals and bacteria. All of these viruses have been assigned to one of 71 
currendy recognized families, 9 subfamilies and 164 genera.
In addition to the ever increasing number of identified viruses, there is now a 
much more precise definition than that given by early virologists. The definitive 
properties of viruses are summarized as follows. A virus is a very small, infectious, 
obligate intracellular parasite. The virus genome is comprised of either DNA or RNA 
and is replicated and directs the synthesis, by cellular systems, of other virion 
components. Within an appropriate host cell, de novo assembly from newly synthesized 
components within the host cell forms progeny virions. A progeny virion assembled
during the infectious cycle is the vehicle for transmission of the viral genome to the next 
host cell or organism.
Recently there has been an increasing prevalence of emergent viruses resulting in 
diseases such as West Nile Fever and Severe Acute Respiratory Syndrome or SARS. It 
seems likely that emergent viruses will become an ever-increasing phenomenon of 
today’s world. With natural geographic barriers to the containment of viruses removed 
by modem modes of transportation the need to study and understand these viruses 
becomes critical to developing strategies to overcome the devastating consequences of 
infection.
One such emergent virus is human immunodeficiency virus (HIV), the causative 
agent of acquired immunodeficiency syndrome (AIDS) (Hahn et al., 1984). Despite 
almost 20 years of intensive research, AIDS remains a devastating disease in many parts 
of the world. With approximately 70 million people infected and more than 20 million 
dead, the AIDS pandemic is still one of the greatest medical challenges the world faces 
(UNAIDS. AIDS epidemic update 2002). The research in this thesis focuses on a 
specific step in the replication cycle of human immunodeficiency virus known as 
genomic RNA dimerization. However, in order to understand the significance of this 
research we must first review retroviruses, focusing on a specific retrovirus, HTV.
Retroviridae
The retroviridae consist of an expansive family of viruses responsible for a 
variety of diseases ranging from malignancies to immunodeficiencies. Depending upon 
their pathogenicity and host range the retroviruses have been divided into three sub­
families: the Oncovirinae (ASLV, MLV, MMTV, HTLV, BLV), the Lentivirinae (HIV, 
FIV, BIV,Visna-Maedi virus, EIAV, CAEV) and the Spumavirinae (SSRY, HSRV).
One unique aspect of retroviruses is that they encapsidate two single-stranded 
positive RNA molecules (8-11 Kb), making them the only diploid viruses identified to 
date (Beemon et al., 1974; Duesberg et al., 1973) Electron microscopy of the virion 
upon gentle lysis revealed that the two RNA strands are non-covalently joined near their 
5’-ends in a region termed the dimer linkage structure (DLS) (figure 1) (Bender and 
Davidson, 1976; Hoglund et al., 1997; Kung et al., 1976).
Figure 1. Upon gentle lysis of the virion an electron micrograph shows the 5’-ends of 
the retroviral RNA joined in a region termed the Dimer Linkage Structure (DLS). 
Figure taken from Hoglund et al, (1997).
The ssRNAs contain a 5’ cap and a 3’ poly (A) sequence, as observed in 
eucaryotic mRNAs (Varmus, 1982). The order of the genes encoding viral proteins is 
invariably gag-pol-env, although for some viruses several open reading frames coding for 
viral accessory/ regulatory proteins interrupt this sequence (Cullen, 1991).
Additional hallmarks of retroviruses are reverse transcription and integration into 
the host genome. The first reported evidence for the existence of an RNA-directed DNA 
polymerase activity in retroviral particles occurred in 1970 with two reports in Nature 
from the laboratories of David Baltimore and Howard Temin (Baltimore, 1970; Temin 
and Mizutani, 1970). With the discovery of reverse transcription, the central dogma of 
molecular biology, that the transfer of genetic information is unidirectional, 
DNA->RNA-^protein, needed to be amended. Thus it became apparent that the flow of 
information could be retrograde, that is RNA could be used as a template for DNA 
synthesis. Hence, viruses capable of reverse transcription came to be known as 
retroviruses.
Encapsidating the dimeric retroviral genome is a roughly spherical vessel 
comprised of viral and cellular proteins as well as lipids derived from the host cell
SU (surface) 
TM (transmcmbrarve)
PR (protcase)
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Figure 2. Diagram of a 
complex retrovirus. 
Indicated are the names 
and locations of the 
component proteins, 
genomic RNA, and 
envelope. Figure taken 
from Flint et al, (2002)
membrane (figure 2). Within the virion, the dimeric RNA is coated with a protein called 
nucleocapsid (NC), with approximately one molecule for every 10 nucleotides (Negroni 
and Buc, 1999). Additional components of the virion include a non-random collection of 
tRNAs necessary for the initiation of reverse transcription, approximately 50 to 100 
molecules of reverse transcriptase (RT) and two other viral enzymes, protease and 
integrase (reviewed in (Frankel and Young, 1998).
As highlighted in figure 3, the major features of the retroviral replication cycle 
include cell binding/ fusion, reverse transcription, integration into the host genome, 
transcription, translation of spliced RNAs, dimerization of full length genomic RNA, 
encapsidation, assembly, and finally release of the viral particle by budding.
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Figure 3. The replication cycle o f  the retrovirus. The major points are highlighted in red 
and blue. Cell binding results in fusion and release o f  the viral components. After reverse 
transcription the viral DNA is incorporated in the host genome. Upon transcription spliced 
RNAs are transcribed into viral proteins while full length genomic RNA is dimerized and 
encapsidated. Finally the virion is assembled and released by budding.
IntCTaction of the virion’s surface proteins with specific host cell receptors results 
in fusion and release of the virion’s contents into the host cell. Nucleocapsid uncoating 
of the genome, induced by reverse transcriptase, allows reverse transcriptase (RT) to 
initiate reverse transcription from a specific tRNA annealed to the primer binding site 
(PBS). Through a complex mechanism involving strand switching, full length genomic 
DNA is produced. Integration into the host genome is achieved via a vitally encapsidated 
integrase resulting in the proviral stage of the replication cycle.
Dming fiie subsequent stages of the replication cycle, the cellular machinery of 
the host is used to transcribe and translate the various viral proteins used for assembly of 
the complete virion. Full length genomic RNA is dimerized and encapsidated and the 
virion is poised for assembly. During assembly, die various enzymes and proteins aloi% 
with the dimeric genome coated m NC are brought together within the viricm. Finally the 
intact virion is released from the host cell by budding. With this brief introduction to 
retroviruses, the focus will now turn to a specific retrovirus, human immunodeficiency 
virus.
AIDS and m V
Acquired immunodeficiency syndrome (AIDS) resulting fi-om HIV infection was 
first recognized in 1981 when a common pattern of symptoms was observed among a 
group of homosexual men in the United States (Brennan and Durack, 1981; Gottlieb et 
al., 1981). Currently an HIV-infected individual is diagnosed with AIDS when their
immune system is seriously compromised and manifestations of HTV infection are severe. 
The U.S. Centers for Disease Control and Prevention (CDC) defines AIDS as the 
presence of one of 26 conditions indicative of severe immunosuppression associated with 
HIV infection, such as Pneumocystis carinii pneumonia, a condition extremely rare in 
people without HIV. Other AIDS-defining conditions are also opportunistic infections, 
rarely causing disease in healthy individuals. HIV-infected individuals are also 
diagnosed with AIDS when their CD4+ T-ceU count falls below 200-cells/cubic 
millimeter of blood (NIH Fact Sheet 2000). Healthy adults have CD4+ T-cell counts of 
600-1,500 per cubic millimeter of blood (NIH Fact Sheet 2000).
At the beginning of this century greater than 36 million people worldwide were 
living with HIV/AIDS (i.e., approximately 35 million adults and 1.5 million children) 
(UNAIDS. AIDS epidemic update 2002). hi the United States an estimated 800,000 to 
900,000 people are living with HTV infection (UNAIDS. AIDS epidemic update 2002). 
Additionally, AIDS is the fifth leading cause of death among all U.S. adults aged 25 to 
44, and among Afiican-Americans it is the leading cause of deatii for men and the second 
leading cause for women (CDC. HIV/AIDS surveillance report 2001)
While most AIDS cases are due to HIV type 1 (HTV-l), another virus, HTV-2, 
infects a significant number of people in West AMca, Southeast Asia and Portugal 
(Reeves and Doms, 2002). Although similar in many ways, there are important 
differences that distinguish fiiem as separate and distinct viruses. Majcn differences
8
include reduced pathogenicity of HTV-2, enhanced immune control of HTV-2 infection 
and often some degree of CD4-independence (Reeves and Doms, 2002).
HTV is thou^t to have originated from zoonotic transmission from simian 
immunodeficiency virus (STV) infected non-human primates (Hahn et al., 2000; Sharp et 
al., 1999; Sharp et al., 1995). Indeed, phylogenetic analysis of the pathogenic 
retroviruses of primates (Figure 4) reveals that HIV-1 is derived from the chimpanzee 
and HTV-2 from the sooty mangabey monkey (Gao et al., 1994; Yamaguchi et d ., 2000).
Figure 4. Ttylogenetic analysis of primate lentiviruses. STVs from chimpanzee cluster 
with HTV-l while HTV-2 clusters witii the sooty mangabey monkey. Figure taken from 
(Reeves and Doms, 2002).
Molecular biology of HIV
Although HTV-l and HTV-2 are less than 50% identical at the nucleotide level, 
they still share important sequence and genomic organization (Guyader et al., 1987) 
(figures 5 and 6). The secondary structure models, represented schematically, for the 5’- 
untranslated regions of HTV-l and HTV-2 genomic RNA are shown in figure 5. The 
Secondary structure elements of known fimction are proposed to attain the same
conformation and are in homologous locations for botii viruses. In HIV-1 the trans­
activation region stem-loop (TAR), the polyadenylation signal stem-loop, and the domain 
containing tiie primer binding site are followed by four small stem-loops necessary for 
genomic RNA dimerization (SLl/DIS), genomic RNA packaging (psi), splicing of the 
viral RNAs (SD) and die initiation of gag translation (AUG). Note the similarities 
between the proposed organization of secondary structure for HTV-l and HTV-2 genomic 
RNAs.
A; HIV-1 B: HIV*2 & SIVsm
P B S
« i»
1»
R Ü 5 Leader Region gag U5 Leader Region gag
Figure 5. Schematic representation ofthe secondary structure of the 5’-untranslated 
region of HIV-1 and HTV-2 genomic RNA. Indicated are the regions with known 
functions. Figure taken from (Jossinet et al., 2001).
The genome organization for HIV-1 and HTV-2 are also similar (figure 6) witii 
each possessing the open reading frames G-antigen (gag), polymerase (pol) and envelope 
(env). Additional genes code for the accessory proteins : negative fiictor protein (nef), 
viral infectivity factor protein (vij), viral protein r (vpr), die response elements rev and tat 
as well as viral protein U (vpu), which is unique to HTV-l.
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Figure 6. Schematic representation of the RNA genomes of HIV-1 and HIV-2. The 
major open reading frames for g-antigen (gag), polymerase (pol) and envelope (env) are 
indicated. Accessory regulatory genes (tat and rev) as well as nonessential genes (nef, vif, 
vpu, vpx, and vpr) are labeled as well. Vpu is found exclusively in HIV-1, whereas vpx is 
found only in HTV-2 and certain strains of STV. Figure taken from Luciw, (1996).
Retroviral Genome Dimerization
It has been definitively established that RNA loop-loop interactions are 
commonly used to establish initial recognition between two RNA molecules (Brunei et 
al., 2002; Greatorex and Lever, 1998). Through either Watson-Crick base pairing or non- 
canonical interactions, hairpin loops can confer either intra- or intermolecular 
associations (Batey et al., 1999; Brion and Westhof, 1997; Pyle and Green, 1995; van 
Batenburg et al., 2001; van Batenburg et al., 2000). These interactions facilitate RNA 
folding by directing local motifs, which can serve as protein recognition signals, active 
catalytic sites, or for coordinating the assembly of modules in complex RNAs (Brunei et 
al., 2002). In addition, long-range interactions coordinate the tertiary structure of RNA 
molecules, which can positively or negatively affect their fates (Dirac et al., 2002;
Lanchy et al., 2003b).
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As previously alluded to, electron microscopy studies of the retroviral genomic 
RNA of Rous sarcoma virus (RSV) revealed that it was dimeric, consisting of two 
homologous ssRNAs associated near their 5’-ends (Mangel et al., 1974; Murti et al., 
1981). The dimeric nature of tiie retroviral genome was further supported by 
sedimentation analysis and gel electrophoresis (Cheung et al., 1972; Fu and Rein, 1993). 
However, additional characterization of the DLS progressed slowly, due to the lack of 
experimental techniques available. However, this changed when Darlix and co-workers 
were able to demonstrate that in vitro transcribed RNAs corresponding to the 5’ region of 
retroviral genomes were able to dimerize in a salt-dependent manner in the absence of 
proteins or other cellular factors (Darlix et al., 1990). With this advance, the process of 
genomic dimerization of retroviruses became more amiable to investigation. In 
particular, the dimerization mechanism for HTV-l genomic RNA has been extensively 
characterized.
Numerous studies have linked the dimerization of the retroviral genome to 
several essential steps of the retroviral replication cycle, including encapsidation, 
translation and reverse transcription (Berkhout and van Wamel, 1996; Clever and 
Parslow, 1997; Haddrick et al., 1996; Hirota et al., 1997; Laughrea et al., 1997; Laughrea 
et al., 1999; Paillart et al., 1996a; St Louis et al., 1998). Thus, understanding the process 
of dimerization becomes essential to developing antiretroviral therapies designed to 
disrupt the process.
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HIV-1 Genomic RNA Dimerization
Initial in vitro studies on HTV-l genomic RNA mapped the dimer linkage 
structure of HTV-l to a region downstream of the splice donor site, containing conserved 
purine tracts that were thought to mediate dimerization through purine quartets (Awang 
and Sen, 1993; Marquet et al., 1991; Sundquist and Heaphy, 1993; Weiss et al., 1993). In 
1994, the cohort of Skripkin et al. utilized chemical modification interference and site 
directed mutagenesis to unambiguously identify the nucleotides that were responsible for 
HTV-l dimerization in vitro (Skripkin et al., 1994). Using chemical modification 
interference, their results identified a short region located upstream of the splice donor 
(SD) site, containing a palindromic sequence, as the region necessary for the initiation of 
genome dimerization (Figure 7).
HlV-1 e
-J P B S  ---------  ------
-G
AG M C U A—̂
C aw G O ■■ C U —  A
y = :
«8 287
R US Leader Region f fS Ê Q  HIV-1 m to ty p m  A / B & D
Figure?. Diagramed is the 5’-untranslated region of HIV-1. To the right the DIS 
is shown in greater detail, the palindromic sequence used to initiate dimerization is 
shaded. Figure taken fi-om (Jossinet et al., 2001)
They next demonstrated that mutations in the palindromic sequence resulted in 
abrogation of dimerization, while deletion of the purine tracts downstream of the SD site 
did not prevent dimerization, showing that the initiation of dimerization does not require 
the presence of purine quartets.
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The initiation of dimerization was proposed to occur through a kissing loop 
mechanism in which the exposed palindromic sequences at the tip of the stem loops 
interacted via Watson-Crick base pairing (figure 8) (Skripkin et al., 1994). Additional 
research verified the existence of the proposed kissing loop complex (Clever et al., 1996; 
Fu et al., 1994; Haddrick et al., 1996; Muriaux et al., 1995; Paillart et al., 1994).
Upon release from the cell, the dimeric genome within the virion undergoes a 
conformational change making it more thermostable (Fu et al., 1994; Laughrea et al., 
2001) . This process was shown to be coordinated by the viral protein nucleocapsid (NC) 
In vivo (Feng et al., 1996). In vitro it was observed that incubation at 37 °C resulted in a 
population of dimeric RNAs that could be dissociated relatively easily (termed loose 
dimers), while incubation at 55 °C produced dimers with significantly more stability 
(termed tight dimers) (Berkhout and van Wamel, 2000). It was proposed that the more 
stable tight dimer had converted from a kissing loop complex to the more extensively 
hydrogen bonded extended duplex (Paillart et al., 1996b). The putative mechanism for 
this conformational switch is shown in figure 8. Additionally, HIV-1 RNA dimerization 
is modulated through elements located upstream and downstream of the DIS via a long 
distance interaction (Abbink and Berkhout, 2003; Berkhout et al., 2002; Huthoff and 
Berkhout, 2001).
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Figure 8. Shown on top are two stem loops poised for the initiation of 
dimerization. The middle Ggnre represents the interactions occurring during the 
kissing-loop complex. The bottom figure shows the base pairing involved in an 
extended duplex. Figure taken firom (Paillart et al., 1996b).
Because of the similarities in genome organization between HTV-l and HTV-2 (see figure 
5) it was initially thought that the mechanism for HTV-2 would be similar to that 
observed for HTV-l. However, as discussed below, this was not to be the case.
HIV-2 Genomic RNA Dimerization
Although it has been proposed that HTV-2 RNA has homologous secondary 
structure to that of HTV-l RNA (Berkhout, 1996), the mechanism of HTV-2 RNA 
dimerization is still a subject of controversy. Initial studies designed to characterize the 
dimerization initiation site of HTV-2 focused on stem loop 1 (SLl) of the genomic RNA. 
Due to SLTs location and overall similarity to the dimerization initiation signal (DIS) in 
HTV-l RNA it seemed logical that SLl would promote genome dimerization of HTV-2
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genomic RNA (figure 5). However, in 2001 research conducted by Jossinet et al. clearly 
showed that the SLl was dispensable for HIV-2 dimerization in vitro (Jossinet et al.,
2001). Specifically, they demonstrated that HIV-2 RNAs truncated to exclude SLl were 
still capable of dimerization. Moreover, the minimal dimerization element of HTV-l (a 
50-mer encompassing HTV-l SLl) was able to dimerize while a 47-mer encompassing 
the SLl of HTV-2 RNA was not. Chemical probing indicated that the HIV-2 SLl 
adopted the expected stem-loop structure, both in the 47-mer RNA and in the 1-5561 
HTV-2 RNA. Further truncation analysis of tiie HTV-2 RNA revealed that a palindromic 
sequence (GGCGCC) located in the primer binding site (PBS) was an in vitro 
dimerization element.
Another group of researchers later submitted a contradictory report, suggesting 
that the SLl of HTV-2 RNA mediated in vitro dimerization and not the palindromic 
sequence located in the PBS (Dirac et al., 2001). In their hands, an HTV-2 RNA 
truncated at the 5’-end of SLl (1-444) was able to dimerize efficiently while another 
HTV-2 genomic RNA truncated at the 5’-end of the PBS domain was not. A critical 
comparison of the in vitro dimerization protocols employed in the previous studies 
revealed significant differences that could account for the observed discrepancies [for a 
thorough review see (Lanchy and Lodmell, 2002)]. Briefly, these differences included 
the length of the RNA used, the incubation time and temperatures, the monovalent 
cations used in the dimerization buffer, as well as the gel electrophoresis conditions used 
to resolve the dimers.
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Also in the Lanchy et al. study, they were able to demonstrate that the 1-444 
RNA, used to establish SLl as the dimerization element of HIV-2 by Dirac et al., was 
unique among the wild-type constructs tested in its ability to utilize SLl to form tight 
dimers; in this instance a tight dimer is referred to as a dimer that is able to resist 
dénaturation during fairly stringent electrophoretic [Tris-Borate EDTA (TEE)] conditions 
at room temperature. Interestingly, by mutating or deleting regions within the PBS or 
SLl, they also demonstrated that disruption of the default dimerization element, the PBS, 
resulted in a switch to the alternative dimerization element, SLl. They further suggested 
that such a phenomenon could represent a switching mechanism that might be utilized 
during the viral replication cycle.
Further characterization of HIV-2 genomic dimerization revealed that sequences 
upstream and downstream of SLl could influence dimerization, suggesting that HTV-2 
genomic RNA, like HTV-l RNA, can adopt an alternative conformation (Dirac et al.,
2002). Additional work by Lanchy et al. precisely mapped the elements upstream and 
downstream of the major splice donor site that influenced the ability of HTV-2 leader 
RNA to dimerize in vitro (Lanchy et al., 2003b). By using a combination of 5’- and 3’- 
truncations of the HTV-2 leader RNA they were able to locate two core elements located 
at nucleotides189-196 and 543-550 that interfered with the formation of SLl-dependent 
tight dimers. They suggested that base pairing between these sequences prevented the 
formation of SLl-dependent tight dimers by sequestering SLl in a stable intramolecular 
conformation. As shown in figure 9, a secondary structure model was generated using M 
fold and chemical probing data, that incorporates the base pairing of the two identified
17
interfering elements and the sequestering of SLl. More recent research has revealed that 
there is another dimerization element for HTV-2 genomic RNA located in a region shown 
to be important for encapsidation in vivo, called the 'R palindrome (Lanchy et al., 2003a).
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Figure 9. Shown is the secondary structure model of the HIV-2 ROD leader 
RNA as predicted using M-fold constrained by results obtained from 
biochemical analysis. The putative long distance interaction is shown to the 
left. The solid lines indicate the PBS and SLl domains and the ^  represents 
the core encapsidation signal (nts 380-408). Figure taken from (Lanchy et al., 
2003b)
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Objectives and experimental design
Dimerization is an essential step in the viral replication cycle and therefore 
represents a potential target for antiretroviral therapy. While the elements necessary for 
dimerization of the HIV-1 genome have been identified, those for HIV-2 are currently 
being characterized and debated. The research presented in this thesis was designed to 
analyze the dimerization-competent conformational variants observed for HTV-2 genomic 
RNA. Using solution structure probing, various HTV-2 constructs were systematically 
modified under several in vitro dimerization conditions and the consequences of 
modification analyzed by primer extension as described below.
The initial specific aims as outlined in my research proposal are as follows:
Specific aim one: Identification of the minimal dimerization domafn of HIV-2.
I will map the dimerization signal(s) by truncation analysis of RNA transcripts 
encompassing the 5'-leader region of HIV-2 genomic RNA.
Specific aim two: Chemical structure probing and secondary structure analysis of 
HIV-2.
Secondary structure maps of monomeric and dimeric RNAs will he constructed using 
data derived from chemical and enzymatic solution structure probing techniques.
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Specific aim three: Chemical modification interference mapping.
Chemically modified RNAs will be subjected to in vitro dimerization assays and the 
consequences of base modification analyzed by primer extension.
Although some of the experimental design had to be modified to adjust for 
unforeseen properties of the HIV-2 genome the basic methods remained the same.
Briefly, various HIV-2 RNA constructs were subjected to solution structure probing 
followed by primer extension to reveal the location of the modifications.
Solution Structure Probing
Nucleic acid modifying reagents are valuable tools for analyzing secondary and 
tertiary structure of RNA molecules. Researchers take advantage of the fact that Watson- 
Crick faces of nucleotides can be chemically modified if the nucleotide is not base-paired 
(figures 10 A and B) (Ehresmaim et al., 1987). Various modification reagents are 
available. For instance, dimethyl sulfate (DMS) alkylates the Watson-Crick positions of 
adenosines (Nl) and cytidines (N3) not involved in base pairing or tertiary-structure, 
while CMCT modifies the N3-position of uridines and, to a lesser extent, the Nl-position 
of guanosines that are not involved in Watson-Crick base-pairing. Additionally, 
enzymatic modification of ssRNAs is also possible. For example, the enzyme RNAse T1 
cleaves 3’ to guanosines and T2 cleaves 3’ to adenosines in ssRNAs.
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Figure 10 A. Sites of chemical modification for adenosine and 
uridine. Modification occurs on the Watson-Crick faces at Nl of 
adenosine and N3 of uridine.
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Figure 10 B. Sites of chemical modification for guanosines and 
cytidines. Modification occurs at the Watson-Crick faces at Nl of 
guanosine and N3 of cytidines.
In order to visualize the modifications, reverse transcription was used. Reverse 
transcriptase generates a complementary copy of DNA (cDNA) from an RNA template. 
When a base in the RNA is chemically modified, or there is a break in the ribose- 
phosphate backbone, the polymerase will pause 3’ to this location (figure 11). Moreover, 
the RNA is modified or digested in a manner that only allows one ‘hit’ per molecule, thus
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allowing analysis of all regions susceptible to modification. These reverse transcription 
products are then resolved on a polyacrylamide sequencing gel. The exact site of 
modification is established by running RNA sequencing reactions in adjacent lanes.
Figure 11. Represented schematically is the process of primer extension. A 
primer is annealed 3’ to the site of modification and reverse transcriptase initiates 
transcription of a cDNA stopping at the site of cleavage or modification.
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Materials and Methods
Template construction for in vitro transcription
A sense primer containing a BamHi. site and the promoter for the phage T7 RNA 
polymerase and an antisense primer containing an £coRI site (IDT Integrated DNA 
Technologies, Inc.) were used to PCR-amplify (Eppendorf) the truncated HIV-2 leader 
RNAs used for the minimal dimerization study (Table 1, oligonucleotides designated nt).
Table 1: Oligonucleotides Used in This Study
F2-1545 5’-AGTTTCTCGCGCCCATC-3 ’
F2-1457 5’-ACCTTCACCCGGAGGC-3’
F2-1 343 5’-CACTCAGGCGTGTTCC-3’
F2-1242 5’-GTCCTAACACACCAGGG-3’
F2-1144 5’-GGCAGCTTTATTAAGAGG-3’
asROD242 5’-GTCTTGTTACTCAGGTGAACACC-3 ’
asROD219 5’-GAATGACCAGGCGGCGACTAGGAG-3’
asEC0444BIS 5’-TTGAATTCGCTCCACACGCTG-3 ’
asEC0325 5’AAGAATTCAAGTCCCTGTTC-3’
asEC0381 5’-TAGAATTCGTTCCTGCCGCCC-3’
ntl97 5’-TAGGATCCTAATACGACTCACTATAGGTCCTAGTCGCCGCC-3’
nt233 5’-TAGGATCCTAATACGACTCACTATAGGTAACAAGACCCTGG-3’
nt253 5’-TAGGATCCTAATACGACTCACTATAGGACCCTTCTTGCTTTGG-3’
nt325 5’-AAGAATTCAAGTCCCTGTTC-3’
nt381 5’-TAGAATTCGTTCCTGCCGCCC-3’
as550 5’-CCCATCTCCCACAATCTTCTACC-3’
The PCR products were fractionated on a 0.8% agarose (FisherBiotech) gel and the DNA 
extracted using the Ultrafree-DNA extraction columns (Millipore) according to the
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manufacturer’s directions. After purification the products were digested with jBa/nHI and 
£coRI restriction enzymes (New England Biolabs) and ligated into the BamHI and £coRI 
sites of the pUC 18 plasmid. Next, DH5a cells were transformed with the plasmids and 
plated onto LB-ampicillin plates (100 pg/mL) and grown overnight at 37° C. Colonies 
were picked, plasmids purified by a mini-prep kit (Eppendorf), and the DNA analyzed by 
restriction digestion, gel-electrophoresis and sequencing (Murdock laboratory. University 
of MT). Once incorporation of the £q)propriate sequence was established it was amplified 
by maxi-plasmid prep (Eppendorf) and used to generate RNA transcripts (see below).
Additionally, a sense primer containing a BamHI site and the promoter for the 
phage T7 RNA polymerase and an antisense primer containing an EcoRI site (IDT 
Integrated DNA Technologies, Inc.) were used to amplify the first 381,444,493, 526 or 
561 nucleotides of the HIV-2 genomic RNA sequence, ROD isolate. The HIV-2 ROD 
DNA template (modified plasmid pRODlO) was provided by the EU Programme 
EVA/MRC Centralised Facility for AIDS Reagents, NIBSC, UK (Grants QLK2- 
CT_1999-00609 and GP828102). The numbering is based on the genomic RNA 
sequence.
RNA synthesis and purification
The different plasmids were linearized with BcoRI (New England Biolabs) and 
the RNAs were generated by an in vitro transcription using the Ampliscribe™ T7 
transcription kit (Epicentre) according to the manufacturer’s directions. Following 
completion of transcription the DNA template was degraded with the supplied RNase-
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free DNase and the RNA precipitated by the addition of 1 volume of 5 M ammonium 
acetate. The RNA was pelleted by centrifugation at 16,436 x g (Sorvall Biofuge Primo 
R, 7597 rotor) at 4 °C, ethanol-washed, resuspended in water, phenolxhloroform (1:1) 
extracted and ethanol precipitated. Finally, the RNAs were subjected to exclusion 
chromatogr^hy (Bio-Gel® P-4, Bio-Rad). Analysis of the absortion spectrum at 260 nm 
and 280 nm allowed for quantification of the RNA (Hewlett Packard 8452 A) and gel- 
electrophoresis (Bio-Rad) was used for qualitative analysis.
In vitro dimerization of HIV-2 RNA
The ability of the RNAs generated in die previous steps to dimerize was analyzed 
by in vitro dimerization assays as described below. The two protocols differ in the 
incubation temperatures and times as well as the electrophoresis conditions employed. In 
our hands, the alternate protocol was found to be equivalent to a protocol employed by 
Dirac et al. to assay for TBE-resistant dimers during electrophoresis (Dirac et al., 2001)
Standard Protocol, adapted from (Jossinet et aL, 2001)
Five pmol of HIV-2 RNA were diluted in 4 p,L of water, denatured at 92 ° C for 
two min and then quench-cooled on ice. After cooling, 1 jrL of 5X monomer buffer (final 
concentrations: 50 mM sodium cacodylate, pH 7.5,40 mM KCl, 0.1 mM MgCla) or 
dimer buffer (final concentrations: 50 mM sodium cacodylate, pH 7.5,300 mM KCl, 5 
mM MgCla) was added. Dimerization was carried out at 37° C for 15 min at which time 
the reactions were immediately placed on ice and subsequently analyzed by ‘native’ gel-
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electrophoresis at 4° C in Tris borate, 45 mM, pH 8.3,0.1 mM MgClz, 0.8% agarose for 
90 minutes at 7 V/cm.
Alternate Protocol adapted from (Dirac et al., 2001)
Five pmol of HIV-2 RNA was diluted in 4 pL of water, denatured at 92 ° C for 
two minutes and then quench-cooled on ice. After cooling, 1 pL of 5X monomer buffer 
(final concentrations; 50 mM sodium cacodylate, pH 7.5,40 mM KCl, 0.1 mM MgClz) or 
dimer buffer (final concentrations; 50 mM sodium cacodylate, pH 7.5,300 mM KCl, 5 
mM MgClz) was added. Dimerization was carried out at 55° C for 30 minutes at which 
time the reactions were immediately placed on ice and subsequently analyzed by agarose 
gel-electrophoresis at 24 °C in Tris borate, 45 mM, pH 8.3,0.1 mM MgCl%, 0.1 mM 
EDTA 0.8% agarose for 90 minutes at 7 V/cm. For both procedures, ethidium bromide- 
stained gels were either scanned with a Fluorescent Image Analyzer FLA-3000 (Fujifilm) 
or photographed directly (Fotodyne).
Enzymatic RNA Probing with RNAse T1
The enzyme RNAse T1 cleaves 3’ to guanosines in ssRNAs. Therefore, this 
method was used to evaluate the base-pairing of guanosines in HTV-2 genomic RNA. A 
stop during primer extension would indicate that the guanosine is located in a single­
stranded region while lack of cleav^e would indicate base-pairing of the guanosine or 
the enzyme’s lack of accessibility.
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In a standard experiment, 5 pmol of HTV-2 leader RNA were diluted in 4 pL of 
water, heated for 2 min at 92° C and quench-cooled on ice. The samples were incubated 
in dimer buffer (final concentrations: 50 mM sodium cacodylate, pH 7.5, 5 mM MgCli, 
300 mM KCl) or monomer buffer (final concentrations: 50 mM sodium cacodylate, pH
7.5.40 mM KCl, 0.1 mM MgCk) for 15 min or 30 min at 37° C or 55° C, respectively. 
The samples were quench-cooled on ice and 2 pg of Escherichia coli tRNA (Sigma) and 
0.11 units of RNase T1 (GibcoBRL) were added. The samples were incubated at 37° C 
for 5 min and ethanol precipitated. The samples were pelleted by centrifugation at
15,000 ipm (Sorvall Biofuge Primo R, 7597 rotor) at 4° C for 30 minutes, ethanol 
washed, vacuum dried (Savant Speed Vac SCI 10) and resuspended in water.
DMS (dimethyl sulfate) chemical probing
Dimethyl sulfate all^lates adenosines at position N l and to a lesser extent 
cytidines at position N3 that are accessible and not base-paired at Iheir Watson-Crick 
faces. In a standard experiment, 5 pmol of HlY-2 leader RNA was diluted in 4 pL of 
water, heated for 2 min at 90° C and quench-cooled on ice. The samples were incubated 
in dimer buffer (final concentrations: 50 mM sodium cacodylate (pH 7.5), 5 mM MgCli, 
300 mM KCl) or monomer buffer (final concentrations: 50 mM sodium cacodylate, pH
7.5.40 mM KCl, 0.1 mM MgClz) for 15 min or 30 minutes at 37° C or 55° C, 
respectively. The samples were quench-cooled on ice, 1 pi of 1:100 DMS (Sigma 
Aldrich), diluted in 95% ethanol, was added and the samples incubated at 37 ° C for 5 
minutes followed by ethanol precipitation. The samples were pelleted by centrifugation
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at 16,436 X  g (Sorvall Biofuge Primo R, 7597 rotor) at 4 °C for 30 minutes, ethanol 
washed, vacuum dried (Savant Speed Vac SCI 10) and resuspended in water.
Oligonucleotide rescue probing
HIV-2 RNA dimers formed at physiological temperatures (37 °C) do not 
withstand dénaturation on Tris-Borate EDTA agarose gels at room temperature (Lanchy 
and Lodmell, 2002). However, an oligonucleotide directed against the 3’-end of die 
RNA (as548 see Table 1) restores the ability to withstand dénaturation (Lanchy et al., 
2003a). In order to evaluate dds phenomenon, RNAs were subjected to chemical and 
enzymatic probing in the presence of as548 as described below.
Chemical and enzymatic probing were as described above with the following changes; 5 
pmol of mV-2 RNA comprising nucleotidesl-561 were diluted in 4 pL of water with or 
without 10 pmol of antisense oligonucleotide as548 (see table 1), heated for 2 min at 92° 
C and quench-cooled on ice. Following modification, the samples were resuspended ia 
IX RQl DNase bufifer (Promega) with 5 units of RQl RNase-firee DNase (Promega) and 
incubated at 37° C for 60 mm. The DNase was removed using EZ micropure enzyme 
removers (Millipore) as per the manufacturer’s directions. The samples were ethanol 
precipitated, pelleted, ethanol washed, vacuum dried (Savant Speed Vac SCI 10) and 
resuspended in water.
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Primer extension
The primer extension reaction proceeds in a three-step process as described by 
Moazed and Noller (1986). In the first step, a sequence specific primer (Table 1) is 
annealed to the HTV-2 leader RNA (modified as described previously). The next step is 
extension which results in the labeling of the DNA product with and the 
extension/specific termination fi-om the primer. The chase reaction continues the 
extension of the primer and insures that all products that are still short, but not yet 
specifically terminated are chased fi'om the gel.
Primer annealing: The DNA oligonucleotides used for primer extension in this study are 
fisted in Table 1. The oligonucleotides were diluted in 4.5X hybridization buffer (50mM 
HEPES, pH 7.0, lOOmM KCl) to 0.2 pmol/pL. 0.4 pmol of primer was added to 0.5 
pmol of target RNA, the samples were heated at 92° C for one min and allowed to slow 
cool to 45° C.
The extension reaction was initiated by the addition of 2 pL of extension mix to a 
final concentration of (.13 mM Tris-HCl (pH 8.5), 69.2 mM KCl, 32 mM MgCli, 32 mM 
dithiothreitol, 5.57 pM dATP, dGTP, dCTP, 0.29 pM dTTP (Amersham), 5.7pCi [a-^^]- 
dTTP (PerkinElmer ) and 0.11 units/pL avian myeloblastosis reverse transcriptase 
(Seikagaku America). The reaction mixtures were incubated at 42° C for 40 min, then 1 
pL of chase mix, 1 mM dATP, dGTP, dCTP, dTTP(Amersham), was added and the 
samples were incubated at 42° C for 15 min.
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The reactions were terminated by the addition of 75 jaL of precipitation buffer 
(70% ethanol, 84 mM NaOAc, pH 6.5, and 0.8 mM EDTA, pH 8.0) with a 10 minute 
incubation at room temperature. The DNA transcripts were pelleted by centrifugation at
14,000 RPM (Eppendorf 5415 C) at room temperature (22 °C average), ethanol washed, 
vacuum dried (Savant Speed Vac SCI 10) and resuspended in 10 pi tracking dye (7M 
urea, IX TBE, 0.025% bromophenol blue and 0.025% xylene cyanol FF). 1 pi of each 
sample was assayed for TTP incorporation by scintillation counting (Packard Tri- 
Carb 1500 liquid scintillation analyzer).
Sequencing was done by the method of Sanger and co-workers (Sanger et al., 
1977). The reactions are as described above with the following additions: prior to 
extension 1.5 pM of a specific ddNTP (Amersham; lane specific. A, G, C and U) was 
added to four individual tubes. Additionally, prior to the chase step, 6.7 pM of a specific 
ddNTP was added to the four previous tubes. The samples were denatured for 2 min at 
92° C and quench-cooled on ice. 1.5 pL of each sample was loaded on an 8% 
polyacrylamide gel (600 x 250 mm) and electrophoresed (Gibco BRL model SA) at 80 
watts for 3-4 hours. The gel was then transferred to filter paper (Whatman 3MM) and 
vacuum dried (Bio-Rad 583 gel dryer) for 30 min at 70° C. The dried gel was either 
exposed on X-ray film (Kodak Biomax MR) for 12-16 hours or an imaging plate (Fuji) 
was applied and subsequently analyzed on the phosphoimager (Fujifilm FLA-3000).
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RESULTS 
Statement of the problem
As previously mentioned, die dimerization of HTV-2 genomic RNA appears to be 
significantly different from that of HIV-1 genomic RNA. Functional studies of HTV-2 
genomic RNA have revealed the presence of three in vitro dimerization elements as well 
as the existence of a long distance interaction that negatively affects tight dimer 
formation. The research conducted for this thesis was done in order to clarify and resolve 
the RNA structural elements and rearrangements involved in HIV-2 genomic RNA 
dimerization.
Overall strategy and design
To resolve the RNA structural elements and rearrangements involved in HIV-2 
genomic RNA dimerization, several HTV-2 RNA constructs were subjected to solution 
structure probing under various in vitro dimerization conditions (see materials and 
methods) (figure 11.5). Briefly, either truncated or mutated HIV-2 leader RNAs were 
dimerized at 37° C for 15 minutes (standard/Jossinet protocol) or 55° C for 30 minutes 
(altemate/Dirac protocol) with or without oligonucleotide as548 present. Dimerization 
was carried out at the different temperatures because of the observation that HTV-1 
genomic RNA formed tight dimers following thermal treatment, most likely due to a 
thermally-induced conformational change (Berkhout and van Wamel, 2000).
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Figure 11.5. Schematic representation of the HIV-2 RNA constructs used in 
this study. The top figure represents the full-length leader region of wild-type 
HFV-2 genomic RNA. Shown are the putative dimerization elements of HIV-2. 
From left to right, the 5' dimer interderence element (DIE), the primer binding 
site palindrome (PBS), the 'P palindrome (T), the SLl palindrome (SLl), and 
the 3' dimer interference element. The line above the 3’ DIE represents the 
region targeted by oligonueleotide as548. The 1-526 construct has the 3' DIE 
removed and the 1 -444 construet is truncated just 3' of SLl. ANAR has the PBS 
plaindrome removed and ADIS has 4 nucleotides in the SLl palindrome 
removed.
Additionally, an HIV-2 RNA construct truncated at the 3’ end of SLl (nucleotides 1-444) 
formed loose dimers at 37 °C but not tight dimers following incubation in dimer buffer at 
55 °C (Dirac et al., 2001 ; Lanchy and Lodmell, 2002). In this case, a tight dimer is 
recognized as one that withstands dénaturation upon eleetrophoresis through a TBE 
agarose gel at approximately room temperature, presumably through more stable 
intermolecular interactions. Oligonucleotide as548 was used to analyze HIV-2 RNA
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dimerization because it was observed that when wild type 1-561 HIV-2 RNA was 
dimerized at 55° C with a 20-fold molar excess of as548, tight dimers were formed 
(Lanchy et al., 2003b).
Thus, the different dimerization protocols made it possible to perform a structural 
analysis of the conformational changes within the HIV-2 RNA by changing only the 
temperature or adding oligonucleotide as548. Following dimerization, the RNAs were 
subjected to solution structure probing either chemically or enzymatically. Because of 
the presence of two dimerization elements in the 393-425 region and one in the PBS 
domain ofHTV2 genomic RNA these were the areas focused on in this study.
Because dimerization represents a critical step in the replication cycle of 
retroviruses, it represents a potential target for antiretroviral therapies. Thus, 
understanding of the mechanism employed by viruses to dimerize their genomic RNA 
becomes essential in developing antiretroviral therapies directed to disrupt the 
dimerization process.
Functional analysis of HIV-2 RNA dimerization elements
As seen in figurel2,1-561 wild-type HTV-2 RNA was not able to form any 
significant amount of tight dimers when incubated at 55 °C and assayed on a Tris Borate 
EDTA (TBE) agarose gel at 28 °C (figure 12, lane 7). However, an HTV-2 RNA 
truncated at the 3'-end of the RNA (1-444) was able to form a tight dimer (figure 12, lane
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3). Moreover, an oligonucleotide directed against nucleotides 397-426 of stem loop 1, 
asDIM, was able to abrogate tight dimerization of the 1-444 construct (figure 12, lane 4).
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Figure 12. Tight dimer formation of 1-444 and 1-561 HIV-2 RNAs. 1-444 and 1-561 
HIV-2 RNAs were incubated at 55 °C in dimer buffer (D), monomer buffer (M), or no 
buffer (C) for 30 minutes. After incubation the RNAs were subjected to 
electrophoresis on a TBE agarose gel at 28 °C. Only tight dimers withstand 
dénaturation. The 1-444 RNA dimers were able to withstand dénaturation upon 
electrophoresis (lane 3) while the 1-561 dimers did not (lane?). The samples were also 
dimerized in the presence of a 20-fold excess of oligonucleotide asDIM, which is 
complementary to nucleotides 397-426 of SLl. The oligo asDIM was able to disrupt 
the ability of 1-444 RNA to form tight dimers (lane 4). Figure taken from (Lanchy et 
al., 2003a)
The existence of a long range interaction between nucleotides upstream and 
downstream of SLl has been reported by our laboratory (see figure 8 in the Introduction) 
(Lanchy et al., 2003b). Moreover, the interaction of nucleotides 189-196 and 543-550 
was shown to modulate dimerization in vitro (Lanchy et al., 2003b). Antisense 
oligonucleotide as202 targets the upstream region of the dimer-interfering element and 
when present during dimerization was able to restore the ability to form tight dimers
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(figure 13, lane 2). Additionally, antisense oligonucleotide as548, which targets the 
downstream region of the dimer-interfering element, was able to restore tight 
dimerization (figure 13, lane 3). The addition of both as202 and as548 resulted in an 
almost complete shift of the RNA to the tight dimer pool (figure 13, lane 8). Moreover, 
the addition of asDIM inhibited tight dimer formation (figure 13, lanes 5, 6, and 9).
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Figure 13. Antisense oligonucleotide-directed restoration and suppression of 
1-561 HIV-2 RNA tight dimerization. 1-561 RNA was incubated at 55 °C for 
30 minutes in dimer buffer with or without a 20 fold excess of the 
oligonucleotides as202, as548 and asDIM or a combination of these. 
Oligonucleotides as202 and as548 target the qpstream and downstream dimer- 
interfering elements, respectively, that were previously identified. Figure 
taken from (Lanchy et al., 2003a)
Surprisingly, mutations in stem loop 1 (SLl) did not result in a decrease of tight 
dimer formation (see figure 14.) As expected, when an RNA lacking nucleotides 409- 
436 of the SLl structure (1-561 ASLl RNA) was incubated in dimer buffer at 55 °C for 
30 minutes, no tight dimer was observed during TBE-agarose gel electrophoresis at 28 °C 
(figure 14 A, lane 1). However, when the same RNA was incubated in the presence of a
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20-fold excess of as548, tight dimers were present during electrophoresis (figure 14, lane 
3). Importantly, the addition of a 20-fold excess of asDIM resulted in suppression of 
tight dimer formation (figure 14, lane 4).
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Figure 14. Oligonucleotide as548-directed rescue of tight dimerization in 1-561 
RNAs lacking SLl and PBS dimerization elements. 1-561 ASLl RNA was 
incubated in dimer buffer at 55 °C for 30 minutes (lane 1) or in the presence of a 20- 
fold excess of asDIM (lane2), as548 (lane3) or both (lane 4). 1-561 ASLl RNA 
lacks nucleotides 409-436 of tiie SLl structure. Figure taken firom (Lanchy et al., 
2003a)
Analysis of this phenomenon revealed the presence of a palindromic sequence 
upstream of SLl in a region previously shown to be involved in in vivo encapsidation 
(Griffin et al., 2001). When 1-561 ASLl RNA was incubated in dimer buffer at 55 °C for 
30 minutes in the presence of a 20-fold excess of oligonucleotides as548 and asv|/, tight 
dimers were not observed during TBE-agarose gel electrophoresis (figure 15 A, lane2). 
Oligonucleotide asT targets nucleotides 392-401 of the core encapsidation signal of HIV-
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2 RNA. Additionally, an RNA lacking both the SLl and PBS dimerization elements 
displayed the same behavior (Figure 15 B, lane 4).
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Figure 15. Oligonucleotide inhibition of HTV-2 RNA tight dimer formation. (A) 1- 
561 ASLl RNA was incubated in dimer buffer at 55° C for 30 minutes (15 A. lane 
1) or in die presence of a 20-fold molar excess of oligonucleotide as'P (16 A, lane2), 
as548 (15 A, laneS) or both (lane 4). 1-561 ASLl RNA lacks nucleotides 409-436 
of the SLl structure. Oligonucleotide as'P targets nucleotides 392-401 of the core 
encapsidation signal of HIV-2 RNA. (B) The conditions are the same as in (A), but 
an fflV-2 construct lacking both the SLl region and the PBS palindrome was used. 
Figure taken from from (Lanchy et al., 2003a)
However, Tris buffer was used in the above experiments while sodium cacodylate 
was used in the solution structure probing assays. Sodium cacodylate is used for solution 
structure probing because of its neutrality toward the modification reagents used. 
Therefore, the oligonucleotide-rescue experiments were repeated to compare the results 
between the two protocols. As can be seen in figure 13, with sodium cacodylate 
replacing Tris, the RNAs still lacked the ability to form significant tight dimers when 
resolved on a TBE agarose gel at approximately room temperature (figure 16, lanes 3,4, 
8,9). However, the addition of a 20-fold excess of oligonucleotide as548 restored the
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RNAs ability to form tight dimers (figure 16, lanes 5 and 10). Additionally, the 1-444 
RNA displayed the same ability to form tight dimers as shown in the previous 
experiments (figure 16, lanes 14 and 15).
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Figure 16. Antisense oligonucleotide-mediated restoration of wild typel-561 
HIV-2 RNA tight dimerization. 1-561 RNAs were incubated for 30 minutes in 
dimer buffer at 55 °C with or without oligonucleotide as548 present. The 
samples were then resolved on a TBE agarose gel at 28 °C. The lanes are as 
indicated; C= control, 1-561 RNA incubated with no buffer, M= 1-561 RNA 
incubated in monomer buffer at 37 °C, Dl= 1-561 RNA incubated in dimer buffer 
at 37 °C, D2= 1-561 RNA incubated in dimer buffer at 55 °C, D3= 1-561 RNA 
incubated in dimer buffer with a 20-fold molar excess of oligonucleotide as548. 
Lanes 1-5 represent wild type 1-561 HIV-2 RNA used in previous experiments. 
Lanes 6-10 represent wild type 1-561 HTV-2 RNA used in the above experiments. 
Lanes 11-15 represent a wild type 1-561 RNA that was truncated at position 444.
The removal of putative dimerization inducing elements did not diminish the 
ability of oligonucleotide as548 to restore tight dimerizaiton. As shown in figure 17, the 
PBS dimer element (lanes 6-10 and). The PBS domain, and the SLl dimer element (lanes 
16-20) have been removed. Additionally, replacing Tris with sodium cacodylate did not 
diminish the ability of as548 to restore dimerization in the mutated RNAs (figure 16, 
lanes 10,15,20).
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__________ as548 as548 asS48
HIV-2 1 561 RNA (p13| HIV-2 (lelia-NAR RNA HIV-2 (lella-PBS RNA HIVJ delts-DIS RNA
Figure 17. Oligonucleotide as548 rescue of HFV-2 RNAs. 1-561 RNAs (pl 3, 
ADIS, ANAR and APBS) were incubated for 30 minutes in dimer buffer at 55 °C 
with or without oligonucleotide as548 present. The samples were then resolved on 
a TBE agarose gel at 28 °C. The lanes are as indicated: C= control RNA with no 
buffer, M= RNA in monomer buffer incubated at 37 °C, Dl -  RNA with dimer 
buffer incubated at 37 °C, D2= RNA with dimer buffer incubated at 55 °C, D3= 
RNA incubated with dimer buffer at 55 °C with a 20-fold excess of 
olieonucleotide as548.
Finally, the minimum amount of oligonucleotide as548 that would rescue tight 
dimerization was determined. This was done because it was observed that as548 
interfered with the primer extension reaction used to visualize modifications after 
solution structure probing (data not shown). As can be seen in figure 18, a 1:1 molar 
ratio of oligonucleotide as548 and HIV-2 RNA shifts a significant proportion of the 
population to the tight dimer pool (compare lane 3 to lane 7). A 2:1 ratio of 
oligonucleotide as548 and HIV-2 RNA resulted in a complete shift of the RNAs to the 
dimer pool (compare lanes 3 and 8). Therefore a 2:1 ratio of oligonucleotide as548 to 
HIV-2 RNA was used for all oligonucleotide-rescue assays described herein.
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picomoies of as548 added to 5 picomoies of HIV-2 
1-661 RNA added during the dimerizaiton reaction
Figure 17. Oligonucleotide as548 titration. 5 picomoies of 1-561 HTV-2 RNA 
was incubated for 30 minutes at 50 °C in dimer buffer with an increasing 
concentration of as548 (in picomoies) as indicated. The samples were resolved 
on a TBE agarose gel at 28 °C. M= 1-561 RNA incubated in monomer buffer at 
37 °C for 15 minutes, C= control 1-561 RNA incubated with no buffer.
Structural analysis of dimerization competent conformational variants within the 
leader region of the HIV-2 genomic RNA.
The data presented above would suggest tiiat HIV-2 RNAs undergo 
conformational rearrangements when using the various in vitro dimerization protocols.
In order to resolve the secondary structures involved in these rearrangements, solution 
structure probing of various HIV-2 constructs was undertaken. Solution structure 
probing provides a way to map the structure of RNAs in solution at nucleotide resolution. 
In this method, enzymatic cleavages or chemical modifications are introduced at a 
statistical and low level at single stranded regions, depending on the probe used (one cut 
or modification per molecule) (Ehresmaim et al., 1987). Primer extension is then used to 
detect stops of transcription at the modified or cleaved nucleotides.
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Structural analysis of stem loop 1 (SLl)
HTV-2 RNA dimers can be functionally divided into two classes, loose and tight 
dimers, based upon their ability to withstand dénaturation during electrophoresis in a 
TBE agarose gel at 28 °C. In order to identify the nucleotides involved in conformational 
rearrangements, solution structure probing was employed. To investigate the secondary 
structure map of HIV-2 RNA, wild-type 1-561 HIV-2 leader RNA was treated witii 
chemical and enzymatic probes. The results obtained ^ e e d  overall with a published 
secondary structure model of HIV-2 genomic RNA (Berkhout, 1996) (figure 18).
PBS
f '  G - C  A^ A^ q G — A ^  ^
?rS I z î  SD Y2 Y3
G — I u  — A- 1Î 0 C — G G
» î î î î î î i ï "  3 P I
a  I f -  _,13 ; ;  g
— A U — A U — G i  n  6  6  G — C A  ̂ U C
G u  — A G — C-375 ‘*A., A G  A — U A A U — A
G — C-120 C — G A C — G 6  — C A A G G C — G -M 7
C — 6  G*~*‘U ü*—“A C “ "G  G c  Q — ^  C — G c —»G
y — G c — G k  c — G U— A A — U U — A C — G A— U
G C A — U ^  C — G ® \ C  — 6  G — C 4g, G — C-<B4 G — C ^  U— A
~  C -----------------------------------------■''‘̂ ~®U(3CUCCX:AUCUUC^~*ACAAACCACGACGGAGU®~^------G------- --------------G------ ? “ SwkAAACUGU*“ '^üGCUAIxF"~®AA6AUUGU6G6AGBB
Figure 18. Proposed secondary structure map of the 5'-untranslated region of 
HIV-2 RNA. The regions of known function are indicated. The authors of this 
map designated SLl as the dimerization initiation site (DIS). Figure taken from 
(Berkhout, 1996).
In a published model, SLl was shown with nucleotides G442 and G440 base 
paired with C398 and C400 (figure 20 B (McCann and Lever, 1997)). However, as can be 
seen in figure 19 A, when probed witii the enzyme RNase Tl, which cleaves 3' of
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unpaired guanosines. nucleotides 442 and 440 are clearly reactive under the conditions 
used in this experiment. The 392-401 region was shown previously to be involved in 
both inter- and intramolecular associations in the HIV-2 RNA (Lanchy et al., 2003a).
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Figure 19. RNase Tl probing of wild-type 1-561 RNA. (A) Lanes 1-4 represent 
sequencing lanes, lane 5 is the RNA primer extended without RNase Tl 
modification. Lanes 6-8 show the RNA after treatment with RNase T l. In lane 5 
the RNA was subjected to dimerization at 55° C with as548 present prior to RNase 
Tl treatment. Lane 6 is the same as lane 5 without as548 present during 
dimerization. In lane 8 the RNA was dimerized at 37 ° C without as548. The 
samples were resolved on an 8% polyacrylamide gel. The reactive nucleotides, 
G430 and G432, are indicated. RNase Tl cleaves 3' of single stranded guanosines. 
(B) Secondary structure model of HlV-2 SLl RNA, as proposed by McCann and 
lever (Abbink and Berkhout, 2003; McCann and Lever, 1997). Nucleotides G430 
and G432, cleaved by RNase Tl, are indicated by asterisks.
As shown in figure 20, there is no change in reactivity of nucleotides G420 or 
G421, located in the SLl palindrome, when subjected to RNase Tl digestion after 
incubation in monomer buffer at 37 °C (figure 20 A, lane 6), dimer buffer at 37 °C 
(figure 20 A, lane 7) or dimer buffer at 55 °C (figure 20 A, lane 8). Nucleotides G420 
and G421 are located at the 3'-end of the palindrome GGUACC located at the apex of
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SLl. These results would suggest that under these conditions nucleotides 420 and 421 
are in a single stranded region that would exclude the use of the SLl palindrome as a 
dimerization element.
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Figure 20. RNase Tl probing of 1-561 RNA in monomer and dimer buffers. (A)
Lanes 1-4 are sequencing lanes. Lane 5 is 1-561 RNA primer extended without RNase 
Tl treatment. Lanes 6-8 show 1-561 RNAs subjected to RNase Tl treatment as 
indicated. Lane 6 shows 1-561 RNA incubated in monomer buffer at 37 in lane 7 was 
1-561 RNA incubated in dimer buffer at 37 and lane 8 is 1-561 RNA incubated in 
dimer buffer at 55 °C. The samples were resolved on an 8% polyacrylamide gel. (B) 
Secondary structure map of HIV-2 SLl. Indicated are nucleotides G420 and G421 tiiat 
are susceptible to RNase Tl cleavage under the conditions described. RNase Tl cleaves 
3' to guanosines in single stranded regions.
oligonucleotide as548, nucleotides G420 and especially G421 show a diminished 
reactivity towards cleavage from RNase Tl. As shown in figure 21 when wild typel-561 
RNA was incubated m dimer buffer at 55° C with a 2-fold molar excess of as548 and 
then subjected to RNase Tl digestion, nucleotides G420 and G421 showed a decrease in 
susceptibility to cleavage (figure 21, lane 6). But, when wild typel-561 RNA was
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incubated in dimer buffer at 55° C or 37° C without as548 the RNA was susceptible to
cleavage (figure 21, lanes 7 and 8).
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Figure 21. RNase T1 probing of wild typel-561 RNA dimerized with or 
without oligonucleotide as548. Lanes 1-4 are sequencing lanes. Lane 5 
showsl-561 RNA primer extended without RNase T1 treatment. Lanes 6-8 
show 1-561 RNAs subjected to RNase T1 treatment as indicated. Lane 6 
showsl-561 RNA incubated in dimer buffer at 55 °C with a 2-fold excess of 
as548, in lane 7 is 1-561 RNA incubated in dimer buffer at 55 °C with no 
as548, and lane 8 is 1-561 RNA incubated in dimer buffer at 37 °C. The 
samples were resolved on an 8% polyacrylamide gel.
Additionally, an HIV-2 RNA construct Avith the PBS palindrome (304-GGCGCC- 
309) deleted (1-561 ANAR RNA) was subjected to RNase XI digestion following 
dimerization as indicated in figure 22. When 1-561 ANAR RNA was incubated in dimer 
buffer at 55° C with as548 the nucleotides G420 and G421 showed a decrease in 
susceptibility to cleavage (figure 22, lane 16). But, when 1-561 ANAR RNA was
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incubated in dimer buffer at 55° C or 37° C without as548 the RNA was susceptible to
cleavage (figure 22, lanes 17 and 18).
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Figure 22. RNase T1 probing of wild typel-561 RNA, 1-526 RNA and 1-561 
ANAR RNAs dimerized with or without oligonucleotide as548. Lanes 1-4 and 11- 
14 are sequencing lanes. Lane 5 is 1-561 RNA primer extended without RNase XI 
treatment. Lanes 6-8 show 1-561 RNAs subjected to RNase XI treatment as 
indicated. Lane 6 showsl-561 RNA incubated in dimer buffer at 55 °C with a 2- 
fold excess of as548, in lane 7 is 1-561 RNA incubated in dimer buffer at 55 °C 
without as548, and lane 8 is 1-561 RNA incubated in dimer buffer at 37 °C. Lanes 
16-18 show ANAR RNA subjected to RNase XI treatment as indicated. Lane 16 
shows ANAR RNA incubated in dimer buffer at 55 °C with a 2 fold excess of as548, 
in lanel7 is ANAR RNA incubated in dimer buffer at 55 °C with no as548, and lane 
18 is ANAR RNA incubated in dimer buffer at 37 °C. Lane 9 and 10 show 1-526 
RNA incubated in dimer buffer at 55 °C and 37 °C, respectively. Xhe samples were 
resolved on an 8% polyacrylamide gel.
Further, a construct truncated at the 3'-end of the HIV-2 leader RNA (1-526 RNA) was 
analyzed and the results were comparable to those seen for the wild typel-561 RNA and 
1-561 ANAR RNA (figure 22, lanes 9 and 10). Oligonucleotide as548 is directed against
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nucleotides 527-548 of the HTV-2 leader RNA. The 1-526 RNA was used because it 
should mimic the effects of adding as548 to full-length wild-type 1-561 RNA.
Solution structure probing of the SLl region with DMS showed that a 
conformational change occurs between the monomeric and dimeric forms of HIV-2 
leader RNA.
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Figure 23. DMS structure probing of 1-561 monomeric and dimeric RNAs. 
(A) Lanes 1-6 are sequencing lanes as indicated above. Lane 7 is a control 
in which 1-561 RNA is primer extended without DMS modification. Lane 8 
is 1-561 incubated in monomer buffer at 37 °C and then DMS modified.
Lane 9 is 1-561 incubated in dimer buffer at 37 °C and the DMS modified. 
The samples were resolved on an 8% polyaciylamide gel. DMS alkylates 
the N1 positions of adenosines and, to a lesser extent, the N3 position of 
cytidines not involved in Watson-Crick base pairing. (B) Secondary structure 
map of HIV-2 SLl (McCann and Lever, 1997). Indicated as dark circles are 
adenosine reactivities when the RNA is incubated in dimer buffer, dark 
triangles represent adenosine reactivities when the RNA is incubated in 
monomer buffer. An increase in the symbol present indicates an increase in 
react]vitv to DMS for that nucleotide.
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Solution structure probing of the \|/ palindrome
Because the v|/ palindrome was shown to be involved in HTV-2 leader RNA 
dimerization, an attempt was made to determine the specific secondary structures 
corresponding to the silenced or dimerization-competent forms of the RNA. The y  
palindromic region following RNase T1 digestion is shown in figure 24. Note the lack of 
cleavage seen for nucleotides G392, G393, G395 and G397 in the palindromic region 
(compare to G404) (figure 24, lanes 6,7, and 8). This lack of reactivity was seen 
whether the RNA was dimerized at 55 °C with as548 (figure 24, lane 6), without as548 
(figure 24, lane 7) or dimerized at 37 °C (figure 24, lane 8).
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Figure 24. RNase T1 digestion of the 'P palindromic region. Lanes 1-4 are 
sequencing lanes. Lane 5 is 1-561 RNA primer extended without RNase T1 
digestion. Lanes 6-8 represent 1-561 RNA subjected to RNase T1 digestion 
following incubation in dimer bufler as indicated. In lane 6,1-561 RNA was 
incubate in dimer buffer at 55 °C for 30 minutes with a 2-fold excess of as548. 
In lane 7,1-561 RNA was incubated at 55 °C for 30 minutes without as548. In 
lane 8,1-561 RNA was incubated in dimer buffer for 15 minutes at 37 °C.
The samples were resolved on an 8% polyacrylamide gel
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When HIV-2 RNA constructs 1-526 (lacking nucleotides 528-561) and 1-561 ANAR 
RNA (lacking nucleotides 304-309) were subjected to RNase T1 digestion, similar results 
were obtained as for the wild type 1-561 RNA (figure 25); specifically, the lack of 
cleavage seen for nucleotides G392, G393, G395 and G397 in the palindromic region.
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Figure 25. RNase T1 probing of 1-561 RNA, 1-526 RNA and ANAR RNAs 
dimerized with or without oligonucleotide as548. Lanes 1-4 and 11-14 are 
sequencing lanes. Lane 5 is 1-561 RNA primer extended without RNase T1 
treatment. Lanes 6-8 show 1-561 RNAs subjected to RNase T1 treatment as 
indicated. Lane 6 showsl-561 RNA incubated in dimer buffer at 55° C with a 2- 
fold excess of as548, in lane 7 isl-561 RNA incubated in dimer buffer at 55° C 
with no as548, and lane 8 is 1-561 RNA incubated in dimer buffer at 37° C. 
Lanes 16-18 show ANAR RNA subjected to RNase T1 treatment as indicated. 
Lane 16 shows ANAR RNA incubated in dimer buffer at 55° C with a 2 fold 
excess of as548, in lanel7 is ANAR RNA incubated in dimer buffer at 55° C 
with no as548, and lane 18 is ANAR RNA incubated in dhner buffer at 37° C. 
Lane 9 and 10 show 1-526 RNA incubated in dimer buffer at 55° C and 37° C, 
respectively. The samples were resolved on an 8% polyacrylamide gel.
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Additionally, when an HIV-2 construct lacking nucleotides 421-424 (1-561 ADIS RNA) 
was subjected to RNase T1 digestion, only mild cleavage of the guanosines in the T  
palindromic region was observed (figure 26, lanes 14-16 as indicated)
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Figure 26. RNase T1 probing of 1-561 RNA, 1-526 RNA and ADIS RNAs 
dimerized with or without oligonucleotide as548. Lanes 1-4 and 9-12 are 
sequencing lanes. Lanes 5 and 13 are 1-561 RNA primer extended without 
RNase T1 treatment. Lanes 6-8 show 1-561 RNAs subjected to RNase T1 
treatment as indicated. Lane 6 showsl-561 RNA incubated in dimer buffer at 
55° C with a 2-fold excess of as548, in lane 7 isl-561 RNA incubated in dimer 
buffer at 55° C with no as548, and lane 8 is 1-561 RNA incubated m dimer 
buffer at 37° C. Lanes 14-16 show ADIS RNA subjected to RNase T1 
treatment as indicated. Lane 14 shows ADIS RNA incubated in dimer buffer 
at 55° C with a 2 fold excess of as548, m lanel5 is ADIS RNA incubated in 
dimer buffer at 55° C with no as548, and lane 16 is ADIS RNA incubated in 
dimer buffer at 37° C. The samples were resolved on an 8% polyacrylamide 
gel.
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Solution structure probing of the primer binding site domain
The palindrome GKjCGCC located at the 5'-end of the primer binding site (PBS) 
was shown to be a default dimerization element for all HIV-2 RNAs incubated at 37° C . 
Additionally, through truncation analysis (Jossinet et al., 2001), site directed mutagenesis 
and oligonucleotide-directed gel shift assays (Lanchy and Lodmell, 2002; Lanchy et al., 
2003b) only one HIV-2 RNA construct (1-444) was shown to utilize the SLl palindrome 
for dimerization when incubated at 55° C (Dirac et al., 2001 ; Lanchy and Lodmell,
2002). To analyze the structural elements involved in this differential use of dimerization 
signals, the PBS domain of HTV-2 RNA was subjected to solution structure probing using 
the various dimerization protocols.
As seen in figure 27, G304, G305 and G307 of the PBS palindrome are only 
mildly susceptible to RNase T1 cleavage with only slight variability between RNA 
constructs (figure 27 A). Some of the residual cleavage observed could be due to a small 
population of the RNAs in a conformation that makes these nucleotides accessible to 
cleavage. However, it has been shown that the PBS does not form tight dimers. Thus, 
the PBS dimers could be dissociating enough to allow a small amount of cleavage.
Located 5' of the PBS palindrome, nucleotides G281 and G282 showed variable 
susceptibility to RNase T1 cleavage with different dimer conditions. Nucleotides G281 
and G282 were strongly cleaved when incubated in dimer buffer at 55 °C (figure 27 A,
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lanes 7 and 14). However, they were only moderately cleaved when the RNA was 
incubated in dimer buffer at 55® C with as548 present, or the 1-526 construct was used 
(figure 27 A, lanes 6, 9, and 13). Total protection of the nucleotides was observed when 
the RNA was incubated in dimer buffer at 37® C (figure 27 A, lanes 8,10,12, 15).
A  1-W i ^ i - à ê â  A m  B
DDDDD DDODD 86GAUCX/W um
PBS g
*  D S S +
oD5S- i
■ D37* r .î
II
%
1 2  3 4 5  5 7  8 'S i c m  13 I3 U I6
Figure 27. RNase XI digestion of HTV-2 RNA constructs 1-561,1-526,1-444 and 
ADIS. (A) Lanes 1-4 are sequencing lanes. Lane 5 is 1-561 RNA primer extended 
without RNase T1 digestion. Lanes 6-15 represent the RNA constructs subjected to 
RNase T1 digestion following incubation in dimer buffer as indicated. In lane 61- 
561 RNA was incubate in dimer buJffer at 55° C for 30 minutes with a 2-fold excess 
of as548. In lane 7,1-561 RNA was incubated at 55° C for 30 minutes without 
as548. In lane 8,1-561 RNA was incubated in dimer buffer for 15 minutes at 37° C. 
In lanes 9 and 10 1-526 RNA was incubated in dimer buffer at 55° C and 37° C, 
respectively. Lanes 11 and 12 show 1-444 RNA incubated in dimer buffer at 55° C 
and 37° C, respectively. In lane 13, ADIS RNA was incubated in dimer buffer at 55° 
C for 30 minutes with a 2-fold excess of as548. In lane 14 ADIS RNA was incubated 
at 55° C for 30 minutes without as548 and m lanel5 ADIS RNA was incubated in 
dimer buffer for 15 minutes at 37 °C. The samples were resolved on an 8% 
polyacrylamide gel. (B) Secondary structure map of HTV-2 SLl. Indicated as dark 
circles are guanosme reactivities when the RNA is incubated in dhner buffer at 55°
C for 30 minutes with a 2-fold excess of as548, clear circles represent guansoine 
reactivities when the RNA is incubated in dimer buffer at 55° C without as548.
Dark squares indicate guanosine reactivities when the RNA is incubated at 37° C 
for 15 minutes. # signifies a non reactive nucleotide in an area of predicted 
accessibility. * signifies a nucleotide with only slight reactivity when dimerized 
using different protocols An increase in die symbol present indicates an observed 
increase m reactivity to RNase T1 cleavage for that nucleotide.
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Finally, the PBS domains of HIV-2 RNAs wild typel-561 and 1-444 were 
subjected to solution structure probing with DMS. This was done because it was 
observed that incubation in dimer buffer at 55 °C for 30 minutes resulted in tight dimer 
formation for the 1-444 RNA but not the wild typel-561 RNA. The DMS reactivities 
observed for the adenosines in the PBS domain are summarized in figure 28. The solid 
circles represent DMS reactivities of the 1-444 RNA, and the clear circles are those 
observed for the wild typel-561 RNA. The only distinct difference between the two 
constructs was a lack of reactivity of adenosines A274-A276 in the wild typel-561 RNA 
construct compared to the 1-444 construct. This region is a GNRA tetraloop and it is 
possible that the 1-444 RNA is in such a conformation as to allow the tetraloop to interact 
with a tetraloop receptor. This interaction would protect these nucleotides form DMS 
modification.
PBS J
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Figure 28. Summary of adenosine reactivities to DMS for HTV-2 RNA constructs 1- 
444 and 1-561 when dimerized at 55 °C for 30 minutes. Shown is the secondary 
structure map of the PBS domain of HIV-2, Berkhout, (1996). The solid circles 
represent DMS reactivites for the 1-444 RNA and the clear circles are those observed 
for the 1-561 RNA.
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Discussion
The characterization of the mechanism of HIV-2 genomic RNA dimerization has 
revealed significant differences with the reported mechanism for HIV-1 RNA. Of these 
differences, the most intriguing is the multiple dimerization elements shown to be used 
by HIV-2 leader region RNA, in vitro. In this study, a structural analysis of the 
dimerization-competent conformational variants of HIV-2 genomic leader RNA was 
undertaken. The results indicate that a rearrangement of secondary structure within the 
HIV-2 leader RNA can be observed when treated using various in vitro dimerization 
protocols. Secondly, the data presented here corroborate and support previous 
experiments demonstrating the use of multiple dimerization elements by HIV-2 RNA.
Stem loop 1 secondary structure
It has been proposed that nucleotides 397401 of the HIV-2 leader RNA base pair 
with nucleotides 443439 to form the base of stem loop 1 (SLl) in HIV-2 RNA (McCann 
and Lever, 1997) (see figure 19 B). However, the data presented herein showed that 
nucleotides G440 and G442 remained susceptible to RNase T1 digestion. Cleavage by 
RNase T1 is indicative of guanosines located in single stranded regions. Additionally, it 
has been shown that nucleotides 392401 can form an intermolecular interaction with a 
homologous region in another HIV-2 RNA (Lanchy et al., 2003a). Further, it has been 
suggested that this region can form an intramolecular interaction with the 5' region of 
stem loop 1 (Lanchy et al., 2003a). Thus, nucleotides 398 and 400 would not be base
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paired with nucleotides 440 and 442, leaving them potentially accessible to RNase T1 
cleavage, as observed (see figure 19). The cleavage of G440 and G442 was observed 
whether the RNA was dimerized at 37° C or 55° C, suggesting a thermostable 
conformation of the HIV-2 RNA that keeps these two nucleotides accessible. Shown in 
figure 29 are two proposed secondary structure models of HIV-2 RNA SLl. Neither 
model fits with the structure probing data obtained in this study.
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Figure 29. Proposed secondary structures of the SLl region of HIV-2 
leader RNA. (A) SLl secondary structure proposed by (McCarm and 
Lever, 1997). In this conformation the stem is extended by base 
pairing of nucleotides 397-401 with nucleotides 443-439. (B) SLl 
secondary structure proposed by (Berkhout, 1996). In this model the T  
palindrome (nucleotides 392-401) was not base paired.
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Solution structure probing of stem loop 1
Solution structure probing of stem loop 1 (SLl) revealed that the palindromic 
sequence (GGUACC) located at the apex of the stem is not used as an in vitro 
dimerization initiation element for full-length wild-type HIV-2 leader RNAs. When 
wild-type 1-561 HIV-2 RNA was incubated in dhner buffer at 37° C or 55° C, 
nucleotides G420 and G421 of the SLl palindrome were both accessible to cleavage by 
RNase XI (see figure 20 A). Because RNase XI cleaves 3’ to unpaired guanosines, the 
observed cleavages would imply that nucleotides G420 and G421 are in a single stranded 
region and not involved in inter- or intramolecular interactions under these conditions. 
Xhis is in agreement with other data from our laboratory that show that SLl is not used 
under most conditions as a dimerization initiation element.
Xo study this further, an assay in which the addition of an oligonucleotide resulted 
in tight dimer formation, reportedly through SLl, was employed (see figures 15-17). 
Oligonucleotide as548 targets the 3’ dimer interference element of HIV-2 RNA, 
disrupting a long distance interaction that abrogates the use of SLl as a dimerization 
element. Xhe benefit of using oligonucleotide as548 is that two dimers that behave 
differently when resolved on agarose gels can be probed in solution without changing the 
incubation conditions.
When wild type 1-561 HIV-2 RNA was dimerized at 55 °C for 30 minutes with a 
2-fold excess of oligonucleotide as548 and then digested with RNase XI, nucleotides
55
G421 and G420 showed a decrease in cleavage intensity (see figure 21). It has been 
demonstrated that oligonucleotide as548 restored tight dimerization via SLl when 
assayed on agarose gels. Thus, the lack of cleavage observed for nucleotides G420 and 
G421 could be due to an intermolecular interaction between RNA molecules resulting in 
the protection of these nucleotides
One HIV-2 RNA construct analyzed, HTV-2 1-526 RNA, lacked the S' element 
shown to be involved in the long distance interaction that normally sequesters SLl, 
making it a nonfunctional dimerization element. Additionally olignucleotide as548 is 
directed against nucleotides 527-548, where the 1-526 RNA ends. Thus, RNase T1 
digestion of 1-526 RNA, following dimerization at 55 °C for 30 minutes, should show 
the same cleavage pattern as the 1-561 RNA dimerized at 55 °C for 30 minutes with a 2- 
fold excess of as548. Indeed this was the case (see figure 22, lanes 9 and 10). Another 
RNA construct, 1-561 ANAR RNA, showed the same cleavage pattern (see figure 22, 
lanes 16-18). 1-561 ANAR RNA lacked nucleotides 304-309 comprising the primer 
binding site palindrome.
These results demonstrate tiiat when nucleotides 527-548 are missing, or targeted 
by an oligonucleotide, there is a conformational switch that involves nucleotides G420 
and G421. Combined with previous data fi-om our lab the results would suggest that 
HIV-2 RNA tight dimerization proceeds through an intermolecular interaction involving 
the SLl palmdrome.
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Solution structure probing of the SLl region of HTV-2 RNA with DMS revealed a 
structural rearrangement between monomeric and dimeric RNAs (see figure 22 A, lanes 8 
and 9). Interestingly, nucleotide A423, located in the middle of the SLl palindrome, is 
reactive under monomeric conditions but protected when incubated in dimer buffer. The 
data presented previously would argue against an intermolecular interaction involving 
A423 under these conditions. Additionally, previous work by our laboratory strongly 
suggests that SLl is not used as the primary dimerization element ofHTV-2 wild type 1- 
561 RNA. However, the protection of A423 in dimeric form could be due to an 
intramolecular interaction.
Indeed, a secondary structure map of wild type 1-561 RNA, generated using M 
fold and structure probing data, showed a conformation of the RNA that would protect 
nucleotide A423 (figure 30). Moreover, the RNA is in a conformation that would 
exclude the use of SLl as a dimerization element.
Solution structure probing of the 'P palindromic region
Previous results in our lab showed the use of an additional dimerization element 
in HIV-2 RNAs lacking functional SLl and PBS palindromes (Lanchy et al., 2003a).
This additional element was shown to be located upstream of SLl, in a region shown to 
be important for encapsidation in vivo (Griffin et al., 2001) . The dimerization element 
was mapped to a palindromic sequence, GGAGUGCUCC, comprising nucleotides 392- 
401 of HlV-2 leader RNA, now called the T  palindrome. RNase T1 digestion of
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polyA signal
Figure 30. Secondary structure model of the HIV-2 ROD leader RNA as 
predicted using M-fold constrained by results obtained from structure probing. 
The putative long distance interaction is shown to the left. The solid lines 
indicate the PBS and SLl domains and the T  represents the core encapsidation 
signal (nts 380-408). Figure taken from (Lanchy et al., 2003b). Nucleotide 
A423 would be protected by an intramolecular interaction as indicated.
dimerized 1-561 RNA showed tiiat the guanosines (G392, G393, G395 and G397) in the 
palindrome were protected from cleavage under all conditions tested (see figure 24). This 
result is not unexpected as it has been suggested that when the 'F palindrome is not being 
used as an intermolecular dimer element it is involved in intramolecular interactions with 
the 5' region of SLl (Lanchy et al., 2003a; Lanchy et al., 2003b).
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When other HTV-2 RNA constructs were dimerized and digested with RNase T l, 
similar cleavage patterns were observed for the guanosines in the T  palindrome as was 
seen for wild type 1-561 RNA(see figures 25 and 26). Specifically, 1-526, ANAR and 
ADIS RNAs were analyzed. ADIS RNA has nucleotides 421-424 of the SLl palindrome 
deleted. An RNA with deletions in SLl was shown previously to use the 'F palindrome 
as an intermolecular dimerization element (Lanchy et al., 2003a). Surprisingly, ADIS 
RNA showed a slight increase in cleavage intensity of guanosines in the T  palindrome 
when compared to the other constructs (see figure 25, lanes 14-16). This could be due to 
the use of another dimerization element in thel-561 ADIS RNA. However, the cleavages 
observed are not very strong, and could be due to a subpopulation of RNAs in a 
conformation in which the guanosines of the T  palindrome are more accessible.
Solution structure probing of the primer binding site domain
As previously discussed, studies on HIV-2 genomic RNA dimerization have 
shown that the PBS palindrome is the default dimerization element for full length wild 
type HTV-2 leader RNA (1-561 RNA), in vitro. Therefore, wild typel-561 RNA was 
dimerized at 37° C, 55° C and at 55° C with a 2-fold excess of as548, followed by RNase 
Tl digestion. As expected the guanosines in the PBS palindrome were only mildly 
susceptible to RNase Tl cleavage when dimerized at 37° C or 55° C (figure 15 lanes 7 
and 8). Guanosines surrounding the PBS palindrome remained susceptible to RNase Tl 
cleavage (0311,0317, G318 and 0323). These data and previous results suggest that
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the protection observed for the guanosines in the PBS palindrome are due to an 
intermolecular interaction involving the dimerization of RNA molecules.
When 1-561 RNA was dimerized at 55° C for 30 minutes with a 2-fold excess of 
as548 the guanosines in the PBS palindrome showed a decrease in RNase Tl cleavage 
intensity compared to dimerization without as548 (figure 26, compare lane 6, 7 and 8).
As shown previously, the 1-561 RNA uses SLl as a dimerization element when 
incubated at 55° C with as548. Thus, the protection of the guanosines in the PBS 
palindrome are most likely not due to an intermolecular interaction of the 1-561 RNAs. 
However, the protections observed could be due to a stable intramolecular interaction of 
these nucleotides, induced by oligonucleotide as548 binding. Additional HTV-2 RNA 
constructs tested (1-526,1-444 and ADIS) showed similar cleavage patterns to those 
observed for the 1-561 RNA (see figure 26, lanes 9-15).
It has been shown that 1-444 RNA incubated in dhner buffer at 55° C for 30 
minutes utilizes SLl for tight dhner formation (Lanchy and Lodmell, 2002). However, 
wild typel-561 RNA, comprising the entire leader region, subjected to the same 
dimerization conditions is unable to form tight dimers. It has been further demonstrated 
that the 1-561 RNA forms a loose dimer, probably a kissing loop complex via the PBS 
palindrome, when dimerized at 55° C for 30 minutes. Therefore, solution structure 
probing of the PBS domains of 1-561 and 1-444 RNAs dimerized at 55° C for 30 minutes 
was performed (see figure 27). The reactivities of adenosines to DMS in the PBS domain 
are summarized in figure 27.
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The only major difference between the two constructs is seen in the 5'-GNRA 
tetraloop (273-GAAA-276). Tetraloops are recognized structural motifs found in RNA 
that can assist in coordinating and stabilizing the folding of a RNA molecule (Costa and 
Michel, 1997). Once formed a tetraloop can form a tertiary interaction by interacting 
with the minor groove of another helix, termed the tetraloop receptor (Michel and 
Westhof, 1990).
The adenosines (A274, A275 and A276) are strongly reactive to DMS in the wild 
typel-561 RNA construct, but protected in the 1-444 RNA construct. It is possible that 
removal of nucleotides 445-561 allows for a conformational change in the RNA that 
forms a tetraloop receptor used by the GNRA tetraloop in the 1-444 construct. This 
interaction of the tetraloop with its receptor would explain the protection observed for the 
adenosines in the 1-444 construct. Moreover, this tertiary interaction, induced by a 
secondary structure rearrangement, could help to stabilize the overall conformation of the 
RNA. Alternatively, the GNRA tetraloop could be the result of a unique conformation of 
the wild type 1-561 RNA not found in the truncated 1-444 RNA. Either way, the data 
suggest a conformational change between an RNA that can form tight dimers (1-444 
RNA) and one that can not (wild type 1-561 RNA).
The biological significance
The dimerization elements used by HIV-2 RNA have been linked to important 
functions in vivo. The PBS palindrome is located in a region where a host-encoded tRNA
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anneals to initialize reverse transcription. The T' palindrome is located in a region shown 
to be important for encapsidation. The use of SLl to form tight dimers in HIV-2 RNA 
has been demonstrated in vitro and for HTV-1 the use of SLl as a dimerization element in 
vivo is thoroughly documented. Finally, the 3’ dimer interfering element 3’- 
GGGUAGAG -5 'comprising nucleotides 550-543 overlaps the AUG (shown in bold) 
translational start codon. Thus it appears that these regions serve the dual purpose of 
fulhlling their role in the replication cycle of the virus and coordinating HIV-2 RNA 
dimerization.
The results of this study demonstrate that thermal treatment of HTV-2 RNA is 
necessary to induce a switch from a loose dimer to a tight dimer. Solution structure 
probing of the RNA in a tight dimer conformation suggests that SLl is involved in the 
formation of these dimers. In vivo, the dimeric RNA within the virion has been shown to 
mature into a more thermostable form, possibly from the formation of an extended 
duplex. Moreover, the nucleotide annealing activity of nucleocapsid protein has been 
shown to coordinate this conformational switch.
Because nucleocapsid protein can aimeal any nucleotides with complementary 
sequences (Dib-Hajj et al., 1993; Paillart et al., 1994), it would be important for the two 
RNAs of the viral genome to be aligned before a stable interaction is introduced. This 
possibility exits In vivo, as the GAG precursor is cleaved to form nucleocapsid after the 
dimerized RNA has been encapsidated. Thus, sequences other than the SLl palindrome 
may be used to correctly ahgn the RNA molecules before nucleocapsid commits the
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molecules to a thermostable tight dimer. The use of the PBS palindrome for the initial 
alignment is interesting because of tiie inability of this region to form tight dimers in 
vitro.
There is additional evidence that suggests that HTV-2 genomic RNA is selected 
for encapsidation co-translationally (Griffin et al., 2001; Kaye and Lever, 1999). 
Moreover, it was shown that nucleotides 380-408 of the genomic RNA are important in 
this process. This is interesting because the 'P palindrome, located in this region, was 
shown to be a dimerization element in HTV-2 RNA when the 5’ end of SLl was deleted. 
Furthermore, the 3’ dimer interfering element contains the AUG translational start codon. 
Thus, it seems possible that the processes of translation, dimerization and encapsidation 
could be coordinated by conformational changes in the RNA.
The data presented here provide structural support for the model of in vivo 
dimerization first presented by Jossinet et al (Jossinet et al., 2001) and furthered by 
Lanchy et al. (Lanchy et al., 2003a). In this model, the newly transcribed RNAs would 
interact in the cytoplasm of the cell through the PBS palindrome due to a conformation 
induced by the long distance interaction that abrogates the use of SLl (figure 31 B and 
C).
63
PBS
T
B
3"
5'.
5 ' DIE 3" DIE
PBS
3'DIE
¥  SLl
5 'DIE
5'
3'
3"
5"
5 ' DIE
PBS
¥  SL l
3'DIE
3'DIE
PBS
¥  SLl
5 'DIE
Figure 32. Schematic Representation of conformational changes in the leader 
region of HTV-2 RNA. (A) Shown are structural elements involved in HIV-2 
genomic RNA dimerization. From left to right, the 5' dimer interfering element 
(DIE), the primer binding site (PBS), the ¥  palindrome (¥), stem loop 1 (SLl) 
and the 3' dimer interfering element (DIE). (B) when the long distance interaction 
of the dimer interfering elements occurs, SLl and ¥  become sequestered. (C) 
with the change in conformation the PBS directs the dimerization of the two RNA 
molecules.
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Figure 33. Schematic Representation of conformational changes in the 
leader region of HIV-2 RNA. (A) The initiation of gag translation begins at 
the AUG start codon located in the 3' dimer interfering element. (B) The 
disruption of the long distance interaction between the 5' and 3' dimer 
interfering elements allows a conformational change in the RNA. This 
conformational switch results in SLl being available for dimerization. Also, 
the primer binding site is now poised to accept a tRNA and the T  
encaps'dation signal is freed to interact with other factors.
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The initiation of gag translation would disrupt this long distance interaction, 
allowing a conformational switch that would not only free SLl but also the core 
encapsidation signal (Figure 32, A). With SLl available, a kissing-loop complex could 
be formed that would free the primer binding site for annealing to a tRNA (Figure 32 B). 
With the T  encapsidation signal exposed it would be available for binding other factors, 
most likely the nucleocapsid domain of the gag polyprotein (Figure 32 B). The dimeric 
RNA would then be encapsidated and the mature nucleocapsid protein could coordinate 
the switch to a more thermostable extended duplex as well as anneal the tRNA to the 
primer binding site.
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